CEPI Grants $41.3 Million to Valneva to Enhance Global Access to First Chikungunya Vaccine The Coalition for Epidemic Preparedness Innovations and Valneva SE have expanded their partnership to enha...
In a strategic move aimed at bolstering its portfolio in inflammatory bowel disease (IBD) treatments, Eli Lilly and Company has announced a definitive agreement to acquire Morphic Holding for approximately USD 3.2 billion. The purchase price represents a 79% premium to Morphic’s closing stock price. Post the tender...
Find More
Ulcerative colitis is a type of inflammatory bowel disease of unknown origin that targets the lining of the colon. Symptoms typically include diarrhea, abdominal pain, discomfort, and the presence of blood in the stool. The severity of the condition can vary, with inflammation affecting just the rectum, extending t...
Find More
Lilly Strengthens IBD Treatment Portfolio with Morphic Acquisition Eli Lilly and Company and Morphic Holding, Inc. announced a definitive agreement for Lilly to acquire Morphic, a biopharmaceutical company developing oral integrin therapies for serious chronic diseases. Lilly will initiate a tender offer to acqu...
Find More
Asensus Surgical Agreed to be Acquired by Karl Storz On June 07, 2024, Asensus Surgical announced that it had entered a deal in which Karl Storz would acquire the company for 35¢ per share in cash. Karl Storz Endoscopy-America, a wholly-owned subsidiary of Germany-based Karl Storz, had agreed to acquire...
Find More
Moderna Reports Successful Phase III Trials for Dual Influenza and COVID-19 Vaccine Moderna, Inc. has reported that its Phase III trial for mRNA-1083, an experimental combination vaccine targeting both influenza and COVID-19, achieved its main objectives by generating a stronger immune response than the approved...
Find More
The Tropion-Lung01 Phase III Trial Reveals that Datopotamab Deruxtecan Significantly Enhanced Overall Survival in Advanced Nonsquamous NSCLC Patients Compared to Chemotherapy The high-level overall survival (OS) results from the TROPION-Lung01 Phase III trial, which had previously met the dual primary endpoint o...
Find More
In the fast-paced and precision-driven world of modern medicine, surgical cameras have emerged as a transformative technology. Among the myriad of technological advancements, surgical cameras stand out as a transformative innovation. These devices have revolutionized the way surgeons perform operations, offering un...
Find More
Over the past few years, the evolution of Smart Pills has been remarkable, driven largely by advancements in technology and innovative developments in healthcare. These pills, equipped with sensors, microprocessors, and wireless communication capabilities, have revolutionized the field of medicine. Technological in...
Find More
Vygon Launched Neonatal Safety in India with Groundbreaking Nutrisafe2 System On March 15, 2024, Vygon, a leader in the production and marketing of specialized medical equipment, introduced Nutrisafe2, a technological leap forward. This state-of-the-art enteral feeding device for neonates guarantees the sa...
Find More
Axial Spondyloarthritis (axSpA) is an umbrella term for a form of inflammatory form of arthritis ass.....
Find More
Primary Progressive Aphasia (PPA) is a rare neurological disorder that results from the damages to t.....
Find More
Blastic plasmacytoid dendritic cell neoplasm (BPDCN), an extremely rare form of neoplasm, generally .....
Find More
Cachexia is a complicated metabolic syndrome related to underlying illness and characterized by musc.....
Find More
Dementia is one of the major chronic and progressive syndrome caused by a number of different condit.....
Find More
An autoimmune disease in which the immune system attacks its healthy skin, Cutaneous Lupus Erythemat.....
Find More-Agonist.png "Toll-like Receptors Agonist")
Live Coverage of ASCO 2024 Visit Now for Real-Time Insights and Analytical, Impactful Updates!
